Compared to the SIRT7-wildtype hepatoma cell line, the SIRT7-deficient cell line exhibited exquisite sensitivity to doxorubicin via the SIRT7-P53-NOXA axis [55]. Here, SIRT7 is linked to hepatocellular carcinoma.